PP

Prakash Pralahadrao Sapkal

Active Director Whole-Time Director DIN 02007385
DIN 02007385 First appointment Sep 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Sep 2001
Shareholding value •••• Premium profile

About Prakash Pralahadrao Sapkal

Data last updated:

Prakash Pralahadrao Sapkal is a Whole-Time Director at Zim Laboratories Limited (since 2013) and Director at Zim Thinorals Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹385 Cr; the largest is Zim Laboratories Limited at ₹385 Cr (FY 2025). Earlier, Prakash Pralahadrao Sapkal was a Director at Zim Health Technologies Limited (2016–2019) and Additional Director at Saif Health Remedies Private Limited (2001–2007).

DIN 02007385
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 29 Sep 2001
Oldest Company Age 42 yrs
Largest company Zim Laboratories Limited · ₹385 Cr (FY 2025)
Combined revenue ₹385 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zim Laboratories Limited L99999MH1984PLC032172
Whole-Time Director22 Nov 20131984₹385 Cr (FY 2025)Active
Zim Thinorals Private Limited U24297MH2021PTC360634
Director18 May 20212021₹66,000 (FY 2026)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zim Health Technologies Limited U24100MH2009PLC193240
Director04 Feb 20162009₹2.68 Cr (FY 2026)Active
Saif Health Remedies Private Limited U55100MH2000PTC126513
Additional Director29 Sep 20012000₹5.57 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Prakash Pralahadrao Sapkal

Directorship timeline

Open interactive timeline →
Zim Thinorals Private Limited
Zim Laboratories Limited
Zim Health Technologies Limited
Saif Health Remedies Private Limited
Premium access

Shareholding and investment profile for Prakash Pralahadrao Sapkal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Pralahadrao Sapkal

Prakash Pralahadrao Sapkal currently holds 2 directorships: Zim Laboratories Limited (Whole-Time Director, since 22 Nov 2013, revenue ₹385 Cr (FY 2025)); Zim Thinorals Private Limited (Director, since 18 May 2021, revenue ₹66,000 (FY 2026)).

Prakash Pralahadrao Sapkal was first appointed on 29 Sep 2001 as Additional Director at Saif Health Remedies Private Limited. The most recent appointment on record is 18 May 2021 at Zim Thinorals Private Limited.

The 2 current companies of Prakash Pralahadrao Sapkal that report revenue have a combined latest revenue of ₹385 Cr: Zim Laboratories Limited ₹385 Cr (FY 2025); Zim Thinorals Private Limited ₹66,000 (FY 2026).

Prakash Pralahadrao Sapkal held 2 earlier board appointments: Zim Health Technologies Limited (Director, 04 Feb 2016 to 04 Jan 2019); Saif Health Remedies Private Limited (Additional Director, 29 Sep 2001 to 30 Sep 2007).

The current boards of Prakash Pralahadrao Sapkal's companies include Anwar Siraj Daud (Zim Laboratories Limited), Ashok Bhatia (Zim Laboratories Limited), Kamlesh Bajirao Shende (Zim Laboratories Limited), Kavita Loya (Zim Laboratories Limited), Niraj Pukhraj Dhadiwal (Zim Laboratories Limited), Padmakar Shrinivas Joshi (Zim Laboratories Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available